AP Health

One of Haiti's most vulnerable and impoverished communities is recovering from a gang attack that targeted a hospital serving as a lifeline for many

China has agreed to curtail shipments of the chemicals used to make fentanyl, the drug at the heart of the U.S. overdose epidemic

RSV infections are rising sharply in some parts of the country, nearly filling hospital emergency departments in Georgia, Texas and some other states

The World Health Organization and the U.S. Centers for Disease Control and Prevention say measles deaths globally spiked by more than 40% last year

The Indian manufacturer of more than a number of eyedrops subject to a U.S. safety warning has officially recalled the products

U.S. health inspectors found a host of sanitation and manufacturing problems at an Indian plant that recently recalled eyedrops sold in the U.S. The problems include cracked floors, barefoot workers and manipulated testing records

One of the thorniest problems of the 21st century is how to get people to eat less meat

Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it had approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020

Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling illness in the U.K. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it had approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020

Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling illness in the U.K. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it had approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020